| MOPEC21 | Using Common Elements Treatment Approach (CETA) to improve access to mental health services among people living with HIV in Rwenzori region in Western Uganda | Poster exhibition | HIV prevention research |
| MOPEC22 | PrEP versus improved HIV Care Cascade: which best drives HIV decline? A mathematical modelling study | Poster exhibition | HIV prevention research |
| OAC0205 | Integration of PrEP services and assisted partner notification into an STI Clinic in Lilongwe, Malawi | Oral abstract session with live Q&A | HIV prevention research |
| OAC0303 | The effect of primary health care on AIDS: a cohort study of 3.4 million individuals in Brazil | Oral abstract session with live Q&A | HIV prevention research |
| OAC0304 | Initiation of pre-exposure prophylaxis (PrEP) among key populations in PEPFAR-supported countries during 2019–2022 | Oral abstract session with live Q&A | HIV prevention research |
| OAC0305 | Increased HIV prevention coverage among Australian gay and bisexual men with regular partners: results of national behavioural surveillance, 2018-22 | Oral abstract session with live Q&A | HIV prevention research |
| OAC0402 | No association between in-utero PrEP exposure and bone mineral density at 36 months of age among mother-infant pairs in Kenya | Oral abstract session with live Q&A | HIV prevention research |
| OAC0404 | Drug-drug interaction between emtricitabine/tenofovir alafenamide (FTC/TAF)-based PrEP and feminizing hormones in transgender women: peripheral blood mononuclear cells and urine analysis from the iFACT3 study | Oral abstract session with live Q&A | HIV prevention research |
| OAC0502 | A pharmacist-led oral PrEP refill visit with client HIV self-testing significantly improved continuation in Kenya | Oral abstract session with live Q&A | HIV prevention research |
| OAC0505 | Increased use of event-driven PrEP during COVID-19 in Australia: results from behavioural surveillance 2019-2021 | Oral abstract session with live Q&A | HIV prevention research |